Stephen E. King
Nessuna posizione attualmente
Profilo
Mr. Stephen E.
King is Vice President-Marketing at AssureRx Health, Inc.
Mr. King was previously employed as Chairman by Synova Healthcare Group, Inc., Chairman & Chief Executive Officer by Synova Healthcare, Inc., Marketing Director-Neurosciences Division by Forest Laboratories, Inc., Vice President-Global Strategic Marketing by Wyeth Corp., a Principal by Smithkline Beecham Pharmaceuticals, and Vice President-Operations by Alkermes, Inc.
He received his undergraduate degree from Brock University.
Precedenti posizioni note di Stephen E. King
| Società | Posizione | Fine |
|---|---|---|
| FOREST LABORATORIES, INC. | Corporate Officer/Principal | 01/08/2003 |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Vendite & Marketing | 01/12/2002 |
| ALKERMES PLC | Corporate Officer/Principal | - |
| Smithkline Beecham Pharmaceuticals (Canada) | Corporate Officer/Principal | - |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Direttore operativo | - |
Formazione di Stephen E. King
| Brock University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ALKERMES PLC | Health Technology |
| Aziende private | 7 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY. | Health Technology |
| Synova Healthcare, Inc. | Health Technology |
Synova Healthcare Group, Inc.
 Synova Healthcare Group, Inc. Medical DistributorsDistribution Services Synova Healthcare Group, Inc. provides healthcare products. It focuses on the development, distribution, marketing and sale of women's healthcare products related to contraception, vaginal health, menopause management, fertility planning, obstetrics and personal care. The company was founded on September 1, 1998 and is headquartered in Media, PA. | Distribution Services |
Assurex Health, Inc.
 Assurex Health, Inc. Pharmaceuticals: MajorHealth Technology AssureRx Health, Inc. operates as a personalized medicine company that develops genetic tests. It specializes in pharmacogenomics, a study of the genetic factors that influence an individual’s response to drug treatments, as well as evidence-based medicine and clinical pharmacology. The firm offers GeneSight, a genetic test that helps healthcare providers to take a personalized approach for prescribing medicine for patients; GeneSight Psychotropic, a test that analyzes genes that affects a patient’s response to antidepressant and antipsychotic medications; and GeneSight Analgesic, a test that analyzes how genes affect the way the body respond to medicines prescribed to treat acute or chronic pain. The company was founded by Donald R. Wright Jr. in 2006 and is headquartered in Mason, OH. | Health Technology |
| Smithkline Beecham Pharmaceuticals (Canada) |
- Borsa valori
- Insiders
- Stephen E. King
